• Product NameCelecoxib
  • CasNo. 169590-42-5
  • MFC17H14F3N3O2S
  • MW381.378
  • Purity
  • Appearancewhite to pale yellow solid
  • Packing
  • Contact usInquiry

Product Details

CasNo: 169590-42-5

MF: C17H14F3N3O2S

Appearance: white to pale yellow solid

Buy Reliable High Purity Quality Celecoxib 169590-42-5 Customized Supply

  • Molecular Formula:C17H14F3N3O2S
  • Molecular Weight:381.378
  • Appearance/Colour:white to pale yellow solid 
  • Vapor Pressure:2.81E-11mmHg at 25°C 
  • Melting Point:157-159 °C 
  • Refractive Index:1.605 
  • Boiling Point:529 °C at 760 mmHg 
  • PKA:9.68±0.10(Predicted) 
  • Flash Point:273.7 °C 
  • PSA:86.36000 
  • Density:1.43 g/cm3 
  • LogP:5.29500 

Celecoxib(Cas 169590-42-5) Usage

Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat mild to moderate pain and to help relieve symptoms of arthritis such as inflammation, swelling, stiffness, and joint pain. It is highly selective in inhibiting COX-2, the form of cyclooxygenase expressed during inflammatory processes, while not affecting the constitutive form COX-1. This selective inhibition helps to reduce the gastric and intestinal toxicity commonly associated with non-selective NSAIDs.

In addition to treating arthritis, Celecoxib has been found effective in patients with familial adenomatous polyposis (FAP). Clinical trials have shown that Celecoxib can reduce the number of colorectal polyps in these patients. It works by reducing hormones that cause inflammation and pain in the body.

169590-42-5 Relevant articles

Bioorthogonal release of sulfonamides and mutually orthogonal liberation of two drugs

Shao, Zhuzhou,Liu, Wei,Tao, Huimin,Liu, Fang,Zeng, Ruxin,Champagne, Pier Alexandre,Cao, Yang,Houk,Liang, Yong

, p. 14089 - 14092 (2018)

Sulfonamide derivatives have been used i...

Synthesis of [11C]celecoxib: A potential PET probe for imaging COX-2 expression

Prabhakaran, Jaya,Majo, Vattoly J.,Simpson, Norman R.,Van Heertum, Ronald L.,Mann, J. John,Kumar, J. S. Dileep

, p. 887 - 895 (2005)

[11C]Labeling of celecoxib, a COX-2 sele...

Rapid Access to N-Protected Sulfonimidoyl Fluorides: Divergent Synthesis of Sulfonamides and Sulfonimidamides

Liu, Yongan,Pan, Qijun,Hu, Xiaojun,Guo, Yong,Chen, Qing-Yun,Liu, Chao

supporting information, p. 3975 - 3980 (2021/05/26)

Herein we report a practical and efficie...

Copper-Catalyzed Reductive Ring-Cleavage of Isoxazoles: Synthesis of Fluoroalkylated Enaminones and Application for the Preparation of Celecoxib, Deracoxib, and Mavacoxib

Wan, Chao,Pang, Jian-Yu,Jiang, Wei,Zhang, Xiao-Wei,Hu, Xiang-Guo

, p. 4557 - 4566 (2021/03/01)

We have identified a new reactivity of c...

Application of (MWCNTs)-COOH/CeO2 hybrid as an efficient catalyst for the synthesis of some nitrogen-containing organic compounds

Heidarzadeh, Tahereh,Nami, Navabeh,Zareyee, Daryoush

, (2021/08/18)

ABSTRACT: Modification of acid functiona...

Nickel(II)-Catalyzed Addition of Aryl and Heteroaryl Boroxines to the Sulfinylamine Reagent TrNSO: The Catalytic Synthesis of Sulfinamides, Sulfonimidamides, and Primary Sulfonamides

Lo, Pui Kin Tony,Willis, Michael C.

, p. 15576 - 15581 (2021/10/02)

We report a redox-neutral Ni(II)-catalyz...

169590-42-5 Process route

4-hydrazinobenzene-1-sulfonamide hydrochloride
17852-52-7,27918-19-0

4-hydrazinobenzene-1-sulfonamide hydrochloride

4-[5-(4-(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulphonamide
169590-42-5,194044-54-7

4-[5-(4-(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulphonamide

Conditions
Conditions Yield
 
 
4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione
720-94-5

4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione

4-sulfamoylphenylboronic acid
613660-87-0

4-sulfamoylphenylboronic acid

4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
331943-04-5

4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide

4-[5-(4-(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulphonamide
169590-42-5,194044-54-7

4-[5-(4-(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulphonamide

Conditions
Conditions Yield
4-sulfamoylphenylboronic acid; With di-tert-butyl-diazodicarboxylate; copper(II) acetate monohydrate; In methanol; at 65 ℃; for 1h;
4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione; With hydrogenchloride; In 1,4-dioxane; methanol; at 20 - 80 ℃;
 

169590-42-5 Upstream products

  • 190711-56-9
    190711-56-9

    4-[5-(4-methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonyl chloride

  • 720-94-5
    720-94-5

    4,4,4-trifluoro-1-(4-methylphenyl)butane-1,3-dione

  • 17852-52-7
    17852-52-7

    4-hydrazinobenzene-1-sulfonamide hydrochloride

  • 74-88-4
    74-88-4

    methyl iodide

169590-42-5 Downstream products

  • 170570-75-9
    170570-75-9

    4-[5-(4-bromomethylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide

  • 170571-00-3
    170571-00-3

    Methylhydroxy-Celecoxib

  • 922499-54-5
    922499-54-5

    celecoxib*nicotinamide

  • 637779-34-1
    637779-34-1

    N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-chlorobutanamide

Relevant Products